SELECTIVE MANUFACTURE OF RECOMBINANT NEUROTOXIN POLYPEPTIDES
    2.
    发明申请
    SELECTIVE MANUFACTURE OF RECOMBINANT NEUROTOXIN POLYPEPTIDES 审中-公开
    重组神经毒素多糖的选择性制备

    公开(公告)号:US20130158235A1

    公开(公告)日:2013-06-20

    申请号:US13814633

    申请日:2011-08-10

    IPC分类号: C07K14/33

    摘要: The present invention pertains to recombinant neurotoxin polypeptides and the manufacture thereof. Specifically, it relates to a polynucleotide encoding a neurotoxin polypeptide comprising a light chain, a linker and a heavy chain, wherein the linker is a modified linker comprising an heterologous amino acid sequence which confers at least one physicochemical property to the polypeptide which allows for separation of partially processed and/or unprocessed neurotoxin polypeptides from processed neurotoxin polypeptides, said heterologous amino acid sequence being flanked N- and C-terminally by a protease recognition and cleavage site Further encompassed by the present invention are vectors and host cells comprising the polynucleotide of the invention as well as polypeptides encoded by the polynucleotide and methods for the manufacture of processed neurotoxin polypeptide.

    摘要翻译: 本发明涉及重组神经毒素多肽及其制造。 具体地说,本发明涉及编码包含轻链,接头和重链的神经毒素多肽的多核苷酸,其中所述接头是包含异源氨基酸序列的修饰接头,所述异源氨基酸序列赋予多肽至少一种物理化学性质,其允许分离 来自加工的神经毒素多肽的部分加工和/或未加工的神经毒素多肽,所述异源氨基酸序列由蛋白酶识别和切割位点N-和C-末端侧接。本发明进一步包括载体和宿主细胞,其包含 以及由多核苷酸编码的多肽和用于制备加工的神经毒素多肽的方法。

    Expression vector for the production of annexin v
    3.
    发明申请
    Expression vector for the production of annexin v 审中-公开
    用于生产膜联蛋白的表达载体v

    公开(公告)号:US20050142657A1

    公开(公告)日:2005-06-30

    申请号:US10499282

    申请日:2002-12-16

    摘要: The invention relates to an expression vector comprising at least those components of the vectors pBR322 or pKK223-3, necessary for the replication thereof, an expression region sequentially comprising, in the reading direction, a first promotor, a binding site specific for a repressor, a sequence corresponding to a prokaryotic ribosome binding site, a cloning site with a gene coding for annexin V, at least one transcription terminator and at least one kanamycin-resistant gene with a second promotor.

    摘要翻译: 本发明涉及至少包含载体pBR322或pKK223-3的那些组分的表达载体,其复制是必需的,其顺序包含在读取方向上的第一启动子,针对阻遏物特异性的结合位点, 对应于原核核糖体结合位点的序列,具有编码膜联蛋白V的基因的克隆位点,至少一个转录终止子和至少一个具有第二启动子的卡那霉素抗性基因。